The shelf itself is not an immediate offering, but it positions the company to raise capital quickly. Monitor for prospectus supplements (424B filings) that indicate actual takedowns — any offering will be limited by the baby shelf rule. Also watch for a reverse stock split announcement to regain Nasdaq compliance, which could be bundled with a capital raise. Given the PRC regulatory risks and pivot to unproven quantum AI, any offering is likely to be highly dilutive.
Price Chart
Executive Summary
Quanome Technologies filed Amendment No. 2 to its S-3 shelf registration, registering up to $120M in securities (common, preferred, debt, warrants, rights, units). The company is a micro-cap ($11M market cap) with PRC pharmaceutical distribution operations, recently disposed of its logistics business, and is pivoting to quantum AI with no revenue from that segment. The shelf is constrained by the 'Baby Shelf Limitation' (max ~$7.95M per 12 months given public float of ~$23.85M), but the filing signals potential future dilution and the company faces Nasdaq bid-price non-compliance (must cure by Jan 4, 2027).
Key Financial Metrics
Key Facts
- Shelf registration for up to $120,000,000 in securities (common, preferred, debt, warrants, rights, units).
- Baby Shelf Limitation applies: cannot sell more than 1/3 of public float (~$23.85M) in any 12-month period, capping actual offerings at ~$7.95M.
- Company received Nasdaq bid-price deficiency notice on Jan 7, 2026; has until Jan 4, 2027 to regain compliance.
- Substantially all business is PRC pharmaceutical distribution through Hupan Pharmaceutical; U.S. logistics business disposed Feb 2026.
- Pivoting to quantum AI/post-quantum cryptography via Cayman subsidiary Quantum Nexus; no revenue from new initiatives.
- As of Sept 2, 2026, 34,427,559 shares outstanding; stock closed at $0.3302 on Sept 1, 2026.
- Company has provided ~$12.7M in aggregate funding to PRC subsidiaries; no dividends paid or planned.
Financial Impact
Shelf registration up to $120M, but Baby Shelf Limitation restricts actual sales to ~$7.95M per 12 months. Potential dilution of up to ~23% of current shares if full baby shelf capacity is utilized at current prices.
Risk Factors
- Nasdaq delisting if bid price not cured by Jan 4, 2027 — could trigger penny stock status and liquidity collapse.
- PRC regulatory risks: CSRC filing requirements for future offerings, cybersecurity reviews, foreign exchange restrictions on dividend repatriation.
- Business model uncertainty: pivot to quantum AI from pharmaceutical distribution with no revenue or concrete plans.
- Massive shelf relative to market cap ($120M vs $11M) signals potential severe dilution, even if constrained by baby shelf.
- Outstanding warrants with anti-dilution provisions could cause additional dilution upon exercise or adjustment.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3/A Filing (Primary) | 0001213900-26-096587 |
| Document: ea030418901ex23-1.htm | 0001213900-26-096587 |
| Document: 0001213900-26-096587-index-headers.html | 0001213900-26-096587 |
| Document: 0001213900-26-096587-index.html | 0001213900-26-096587 |
| Document: 0001213900-26-096587.txt | 0001213900-26-096587 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 8-K | $0.4427 $0.4097 | ▲ +7.45% | ▲ +6.93% | $0.4150 (+6.26%) |
Oct 21, 2026 5d ago | 424B5 | $0.4427 $0.4097 | ▲ +7.45% | ▲ +6.93% | $0.4150 (+6.26%) |
Oct 19, 2026 8d ago | EFFECT | $0.5356 $0.4740 | ▲ +11.50% | ▲ +11.84% | $0.4150 (+22.52%) |
Oct 5, 2026 22d ago | 8-K | $0.5790 $0.5220 | ▼ −9.84% | ▼ −10.39% | $0.4150 (−28.32%) |
Oct 1, 2026 25d ago | S-3/A | $0.5382 $0.5600 | ▲ +4.05% | ▲ +3.31% | $0.4150 (−22.89%) |
Oct 1, 2026 25d ago | Press Release | $0.5382 $0.5600 | ▲ +4.05% | ▲ +3.31% | $0.4150 (−22.89%) |
Sep 23, 2026 4w ago | 8-K | $0.8390 $0.8047 | ▼ −4.09% | ▼ −4.01% | $0.4150 (−50.54%) |
Sep 21, 2026 5w ago | 8-K | $0.8509 $0.8390 | ▼ −1.40% | ▼ −0.68% | $0.4150 (−51.23%) |
Sep 2, 2026 7w ago | S-3/A | $0.3280 $0.3241 | ▲ +1.19% | ▲ +2.24% | $0.4150 (−26.52%) |
Aug 20, 2026 9w ago | 8-K | $0.3405 $0.3294 | ▼ −3.26% | ▼ −3.67% | $0.4150 (+21.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers